Skip to main content

TRANSCAT INC. Value Stock - Dividend - Research Selection

Transcat

ISIN: US8935291075 , WKN: 923106

Market price date:
Market price:  


Fundamental data and company key figures of the share

Annual reports in
Key figures
Cash flow
Net operating cash flow
Capital Expenditures
Free cash flow
Balance sheet
Total Equity
Liabilities & Shareholders equity
Income statement
Net income
Eps (diluted)
Diluted shares outstanding
Net sales/revenue

Fundamental ratios calculated on:

Ratios
Key figures
Cash flow
P/C
 
P/FC
Balance sheet
ROI
ROE
Income statement
P/E
Div. Yield %
P/B
P/S


Do you want to do make a detailed fundamental analysis of this stock?

✓ NEW Fundamental API Access to 500 data points per month
Fundamental data up to 25 years
Comparison to all other stocks by the FScore
Time saving!

How our site works ...

Non-binding 7 days without automatic subscription
 No termination required after the free week
Finanzoo fundamental analysis
Data updated daily
Virtual depots
Share alarms via email
Subscription can be canceled at any time at the end of the month 
Choice of desired shares
Over 2000 stock analyzes available
Bitcoin payment possible if you do not want to subscribe

Price for monthly subscription $ 19.99 / month including VAT.



Description Data
Symbol
Market Capitalization USD
Country
Indices
Sectors
Raw Data Source
Stock Split
Internet


Description of the company

Transcat, Inc. provides calibration and laboratory instrument services in the United States, Canada, and internationally. It operates in two segments, Service and Distribution. The Service segment offers calibration, repair, inspection, analytical qualifications, preventative maintenance, consulting, and other related services. This segment also provides CalTrak, a proprietary document and asset management system that is used to integrate and manage the workflow of its calibration service centers and customers\' assets; CalTrak Online, which provides its customers with Web-based asset management capability, as well as an off-site archive of calibration and other service records; and Compliance, Control and Cost, a cloud-based customer portal and asset management tool. The Distribution segment distributes approximately 100,000 test, measurement, and control instruments for customers\' test and measurement instrumentation needs. This segment markets and sells its products through Website, digital and print advertising, proactive outbound sales, and an inbound call center. The company provides services and products to highly regulated industries, principally life science, which includes companies in the pharmaceutical, biotechnology, medical device, and other FDA-regulated industries; and additional industries, including industrial manufacturing, oil and gas and alternative energy, aerospace and defense, and other industries that require accuracy in processes and confirmation of the capabilities of their equipment. Transcat, Inc. was founded in 1964 and is headquartered in Rochester, New York.

The Finanzoo GmbH assumes no liability for the accuracy of the information! All information is provided without warranty. Sources:: www.bundesanzeiger.de, www.sec.gov,


NEWS


3 of Wall Street’s Favorite Stocks We Keep Off Our Radar

2026-09-08
The stocks in this article have caught Wall Street’s attention in a big way, with price targets implying returns above 20%. But investors should take these forecasts with a grain of salt because analysts typically say nice things about companies so their firms can win business in other product lines like M&A advisory.

1 Profitable Stock with Solid Fundamentals and 2 We Find Risky

2026-08-31
Not all profitable companies are built to last - some rely on outdated models or unsustainable advantages. Just because a business is in the green today doesn’t mean it will thrive tomorrow.

Transcat Expands its Biomedical Calibration Channel with the Acquisition of Southeastern Biomedical

2026-08-31
ROCHESTER, N.Y., August 31, 2026--Transcat Expands its Biomedical Calibration Channel with the Acquisition of Southeastern Biomedical

Transcat to Participate in Jefferies, Lake Street and D.A. Davidson Investor Conferences in September

2026-08-27
ROCHESTER, N.Y., August 27, 2026--Transcat to Participate in Jefferies, Lake Street and D.A. Davidson Investor Conferences in September

5 Revealing Analyst Questions From Transcat’s Q2 Earnings Call

2026-08-13
Transcat’s second quarter saw the company exceed Wall Street’s revenue and non-GAAP profit expectations, powered by double-digit gains in both its Service and Distribution segments. Management pointed to particularly strong performance in regulated end markets such as life sciences, aerospace, and energy, where Transcat’s calibration business continues to gain market share. CEO Jaime Irick highlighted operational improvements and integration of recent acquisitions as key to the quarter’s growth,

Transcat (TRNS) Q1 2027 Earnings Call Transcript

2026-08-12
Service margins expanded as revenue grew 22% to $92.9 million.

Transcat, Inc. Q1 2027 Earnings Call Summary

2026-08-05
Moby summary of Transcat, Inc.'s Q1 2027 earnings call

Transcat, Inc. 2027 Q1 - Results - Earnings Call Presentation

2026-08-05
2026-08-05. The following slide deck was published by Transcat, Inc.

Transcat Inc (TRNS) (Q1 2027) Earnings Call Highlights: Strong Service Growth and Strategic ...

2026-08-05
Transcat Inc (TRNS) reports 22% revenue growth in Q1 2027, with service revenue up 27% and management confident in achieving high single-digit organic growth for the fiscal year.

Transcat Q1 Earnings Call Highlights

2026-08-05
Transcat (NASDAQ:TRNS) reported first-quarter fiscal 2027 revenue of $92.9 million, up 22% from a year earlier, as both its calibration services and distribution segments posted double-digit growth. The company said demand remained strong across its regulated end markets, including life sciences, ae